Total Payments
$41,377
2024 Payments
$13,807
Companies
22
Transactions
147
Medicare Patients
822
Medicare Billing
$39,412
Payment Breakdown by Category
Other$18,636 (45.0%)
Consulting$12,884 (31.1%)
Food & Beverage$8,559 (20.7%)
Travel$1,144 (2.8%)
Education$98.59 (0.2%)
Gifts$56.04 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $12,884 | 12 | 31.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $9,500 | 10 | 23.0% |
| Food and Beverage | $8,559 | 103 | 20.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,350 | 5 | 17.8% |
| Honoraria | $1,786 | 2 | 4.3% |
| Travel and Lodging | $1,144 | 8 | 2.8% |
| Education | $98.59 | 4 | 0.2% |
| Gift | $56.04 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Carl Zeiss Meditec, Inc. | $20,023 | 40 | $0 (2024) |
| Tarsus Pharmaceuticals, Inc. | $9,037 | 15 | $0 (2024) |
| Allergan, Inc. | $2,167 | 24 | $0 (2021) |
| ABBVIE INC. | $1,437 | 5 | $0 (2023) |
| Horizon Therapeutics plc | $1,306 | 6 | $0 (2023) |
| Regeneron Pharmaceuticals, Inc. | $1,264 | 6 | $0 (2024) |
| Oyster Point Pharma, Inc. | $1,017 | 6 | $0 (2023) |
| ImmunoGen, Inc. | $817.00 | 2 | $0 (2023) |
| Apellis Pharmaceuticals, Inc. | $786.00 | 1 | $0 (2024) |
| Shire North American Group Inc | $660.25 | 12 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,807 | 30 | Tarsus Pharmaceuticals, Inc. ($9,037) |
| 2023 | $3,349 | 15 | Carl Zeiss Meditec, Inc. ($1,896) |
| 2022 | $5,014 | 22 | ABBVIE INC. ($1,287) |
| 2021 | $1,854 | 14 | Allergan, Inc. ($1,192) |
| 2020 | $4,417 | 12 | Carl Zeiss Meditec, Inc. ($4,017) |
| 2019 | $6,608 | 22 | Carl Zeiss Meditec, Inc. ($5,908) |
| 2018 | $1,132 | 8 | Carl Zeiss Meditec, Inc. ($626.93) |
| 2017 | $5,196 | 24 | Carl Zeiss Meditec, Inc. ($4,000) |
All Payment Transactions
147 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA (Biological) | Consulting Fee | Cash or cash equivalent | $789.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA (Biological) | Consulting Fee | Cash or cash equivalent | $131.50 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/25/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $157.25 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/25/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/07/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $95.22 | General |
| Category: Ophthalmology | ||||||
| 11/07/2024 | Alcon Vision LLC | — | Food and Beverage | In-kind items and services | $59.86 | General |
| 11/07/2024 | Tarsus Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $52.94 | General |
| 11/07/2024 | Topcon Healthcare, Inc. | — | Food and Beverage | Cash or cash equivalent | $45.65 | General |
| 11/06/2024 | Apellis Pharmaceuticals, Inc. | — | Honoraria | Cash or cash equivalent | $786.00 | General |
| 10/23/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $131.77 | General |
| Category: Glaucoma | ||||||
| 10/03/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
| 08/21/2024 | Tarsus Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| 08/21/2024 | Tarsus Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,475.00 | General |
| 06/21/2024 | Tarsus Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $80.49 | General |
| 06/20/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 06/10/2024 | Carl Zeiss Meditec, Inc. | CIRRUS HD-OCT (Device), CLARUS, CLARUS | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: Optical Tomography | ||||||
| 04/17/2024 | Carl Zeiss Meditec, Inc. | CIRRUS HD-OCT (Device), CLARUS, FORUM | Consulting Fee | Cash or cash equivalent | $962.50 | General |
| Category: Optical Tomography | ||||||
| 04/17/2024 | Tarsus Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $640.95 | General |
| 04/11/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $132.58 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 03/21/2024 | Astellas Pharma Global Development | Izervay (Drug) | Food and Beverage | In-kind items and services | $60.86 | General |
| Category: Ophthalmology | ||||||
| 03/15/2024 | Topcon Healthcare, Inc. | — | Food and Beverage | Cash or cash equivalent | $141.34 | General |
| 03/13/2024 | Carl Zeiss Meditec, Inc. | IOLMaster 700 (Device), MEL 90, VisuMax | Food and Beverage | In-kind items and services | $217.41 | General |
| Category: Optical Biometer | ||||||
| 03/07/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 02/08/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $219.71 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 02/08/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $33.73 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 10 | 392 | 413 | $116,640 | $17,202 |
| 2021 | 6 | 304 | 354 | $117,960 | $14,777 |
| 2020 | 5 | 126 | 135 | $44,230 | $7,433 |
Total Patients
822
Total Services
902
Medicare Billing
$39,412
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92004 | New patient complete exam of visual system | Facility | 2022 | 65 | 65 | $38,350 | $4,986 | 13.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 59 | 66 | $13,200 | $3,965 | 30.0% |
| 92014 | Established patient complete exam of visual system | Facility | 2022 | 72 | 72 | $35,280 | $3,666 | 10.4% |
| 92083 | Exam of visual field with extended testing | Facility | 2022 | 55 | 65 | $7,340 | $1,459 | 19.9% |
| 92012 | Established patient problem focused exam of visual system | Facility | 2022 | 32 | 32 | $10,880 | $1,022 | 9.4% |
| 92133 | Imaging of optic nerve | Facility | 2022 | 49 | 50 | $5,500 | $885.90 | 16.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 13 | 14 | $1,750 | $477.36 | 27.3% |
| 92020 | Exam of the internal drainage system of eye | Facility | 2022 | 21 | 21 | $2,310 | $349.91 | 15.1% |
| 92134 | Imaging of retina | Facility | 2022 | 11 | 13 | $1,430 | $296.55 | 20.7% |
| 76514 | Ultrasound scan of cornea to determine thickness | Facility | 2022 | 15 | 15 | $600.00 | $95.38 | 15.9% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Facility | 2021 | 83 | 116 | $39,440 | $4,976 | 12.6% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Facility | 2021 | 56 | 56 | $33,040 | $4,345 | 13.2% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Facility | 2021 | 65 | 67 | $32,830 | $3,400 | 10.4% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Facility | 2021 | 44 | 55 | $6,050 | $1,107 | 18.3% |
| 92133 | Diagnostic imaging of optic nerve of eye | Facility | 2021 | 40 | 42 | $4,620 | $671.16 | 14.5% |
| 92020 | Examination of cornea and iris using lens device and slit lamp | Facility | 2021 | 16 | 18 | $1,980 | $277.95 | 14.0% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Facility | 2020 | 37 | 37 | $14,770 | $2,709 | 18.3% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Facility | 2020 | 46 | 55 | $16,780 | $2,582 | 15.4% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Facility | 2020 | 17 | 17 | $9,070 | $1,538 | 17.0% |
| 92083 | Measurement of field of vision during daylight conditions | Facility | 2020 | 14 | 14 | $2,110 | $356.30 | 16.9% |
| 92133 | Diagnostic imaging of optic nerve of eye | Facility | 2020 | 12 | 12 | $1,500 | $247.32 | 16.5% |
About Dr. Daniel Epshtein, O.D
Dr. Daniel Epshtein, O.D is a Optometrist healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2015. The National Provider Identifier (NPI) number assigned to this provider is 1750763769.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Epshtein, O.D has received a total of $41,377 in payments from pharmaceutical and medical device companies, with $13,807 received in 2024. These payments were reported across 147 transactions from 22 companies. The most common payment nature is "Consulting Fee" ($12,884).
As a Medicare-enrolled provider, Epshtein has provided services to 822 Medicare beneficiaries, totaling 902 services with total Medicare billing of $39,412. Data is available for 3 years (2020–2022), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Location Brooklyn, NY
- Active Since 06/25/2015
- Last Updated 02/24/2017
- Taxonomy Code 152W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1750763769
Products in Payments
- CIRRUS HD-OCT (Device) $11,100
- CLARUS 500 Fundus Camera (Device) $4,559
- XDEMVY (Drug) $3,088
- CLARUS (Device) $1,884
- VUITY (Drug) $1,287
- XIIDRA (Drug) $1,262
- Glaucoma Workplace (Device) $1,250
- TEPEZZA (Drug) $1,185
- EYLEA (Biological) $1,181
- TYRVAYA (Drug) $1,017
- Elahere (Biological) $817.00
- DURYSTA (Drug) $815.70
- VYZULTA (Drug) $655.02
- FORUM (Device) $535.44
- Rhopressa (Drug) $497.20
- LUMIGAN (Drug) $432.21
- RESTASIS (Drug) $406.52
- RESTASIS MULTIDOSE (Drug) $275.96
- CIRRUS 6000 (Device) $250.00
- IOLMaster 700 (Device) $217.41
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Brooklyn
Dr. Justin Bazan, Od, OD
Optometrist — Payments: $511,024
Optometrist $511,024
Katherine Mastrota, Od, OD
Optometrist — Payments: $56,972
Optometrist $56,972
Dr. Marcien Pierre, Od, OD
Optometrist — Payments: $7,455
Optometrist $7,455
Dr. Sally Chetrit, O.d, O.D
Optometrist — Payments: $6,327
Optometrist $6,327
Dr. Natalya Rooney, Od, OD
Optometrist — Payments: $6,200
Optometrist $6,200
Viktoriya Gutkevich, O.d, O.D
Optometrist — Payments: $5,616
Optometrist $5,616